21 – 27 November 2016
Field trial of genetically modified mosquitoes gets approval in Florida
A field trial of genetically modified mosquitoes has been approved in Florida, but several steps remain before the trial can actually get going. Find source
NgAgo gene-editing controversy escalates
Chinese researchers reported that an enzyme called NgAgo could be used to edit mammalian genes — and that it might be more accurate and more versatile than the popular CRISPR–Cas9 gene-editing technique. Find source
Study raises caution about anti-aging benefits of blood transfusions from the young
The author of a study published Tuesday cautioned against the idea that transfusions of “young” blood can reverse the aging process, a notion that has captured the public imagination and motivated startups. Find source
Blow to cancer therapy
Two patients trialling a promising but risky cancer therapy have died following severe brain swelling. It’s the second time that the experimental therapy, from Juno Therapeutics in Seattle, Washington, has been tied to fatal side effects. Find source
3D embryo atlas reveals human development in unprecedented detail
Human-embryo development has been revealed in unprecedented detail by an interactive 3D atlas that took scientists 45,000 hours to produce. Find source
